According to the Oncology Nursing Society’s new position statement, “Role of the Oncology Nurse Navigator Throughout the Cancer Trajectory,” oncology nurse navigators are crucial to the successful outcomes of patients with cancer. Through clinical expertise, care coordination skills, and leadership abilities, ONNs are able to guide their patients during the cancer trajectory.
In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL).
